Immunovant (IMVT) Return on Equity [ROE] (2019 - 2026)
Immunovant's Return on Equity [ROE] was -67.79% in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 0.19 percentage points from -67.98% a year earlier but down 12.79 percentage points from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Return on Equity [ROE] (2019 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Return on Equity [ROE] at Immunovant came in at -64.82%, down 2.36 percentage points from FY2025.
- Return on Equity [ROE] has now declined for four consecutive fiscal years, with a five-year change of -20.57 percentage points (FY2021 to FY2026).
- In earlier fiscal years, Return on Equity [ROE] was -62.46% in FY2025 (-9.54 pp), -52.91% in FY2024 (-2.22 pp), -50.69% in FY2023 (-14.30 pp) and -36.39% in FY2022 (+7.86 pp).
- Quarterly Return on Equity [ROE] has moved between -95.48% (fiscal Q3 2025) and -26.44% (fiscal Q3 2022) over five years.
- Compared with a year earlier, Return on Equity [ROE] has increased for three straight quarters, with an average year-over-year change of -4.39 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was fiscal Q3 2026 (a gain of 33.82 percentage points); the worst was fiscal Q2 2024 (a drop of 50.04 percentage points).
- Per Business Quant data, IMVT's Return on Equity [ROE] in the three fiscal quarters before Q1 2027 was -55.00% (Q4 2026), -61.65% (Q3 2026) and -82.37% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Immunovant | 7.38 Bn | 3.97 Bn | - | -73.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -73.11% |
| Jun 30, 2026 | -67.79% |
| Mar 31, 2026 | -55.00% |
| Dec 31, 2025 | -61.65% |
| Sep 30, 2025 | -82.37% |
| Jun 30, 2025 | -67.98% |
| Mar 31, 2025 | -78.08% |
| Dec 31, 2024 | -95.48% |
| Sep 30, 2024 | -65.01% |
| Jun 30, 2024 | -46.89% |
| Mar 31, 2024 | -39.99% |
| Dec 31, 2023 | -52.29% |
| Sep 30, 2023 | -92.54% |
| Jun 30, 2023 | -73.83% |
| Mar 31, 2023 | -54.29% |
| Dec 31, 2022 | -49.04% |
| Sep 30, 2022 | -42.50% |
| Jun 30, 2022 | -36.77% |
| Mar 31, 2022 | -32.15% |
| Dec 31, 2021 | -26.44% |
API Access
Immunovant Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();